TW239861B - - Google Patents

Info

Publication number
TW239861B
TW239861B TW082102440A TW82102440A TW239861B TW 239861 B TW239861 B TW 239861B TW 082102440 A TW082102440 A TW 082102440A TW 82102440 A TW82102440 A TW 82102440A TW 239861 B TW239861 B TW 239861B
Authority
TW
Taiwan
Application number
TW082102440A
Other languages
Chinese (zh)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929206989A external-priority patent/GB9206989D0/en
Priority claimed from GB929217827A external-priority patent/GB9217827D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of TW239861B publication Critical patent/TW239861B/zh

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
TW082102440A 1992-03-31 1993-04-01 TW239861B (enrdf_load_stackoverflow)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929206989A GB9206989D0 (en) 1992-03-31 1992-03-31 Chemical compounds
GB929217827A GB9217827D0 (en) 1992-08-21 1992-08-21 Chemical compounds

Publications (1)

Publication Number Publication Date
TW239861B true TW239861B (enrdf_load_stackoverflow) 1995-02-01

Family

ID=26300619

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082102440A TW239861B (enrdf_load_stackoverflow) 1992-03-31 1993-04-01

Country Status (4)

Country Link
CN (1) CN1081677A (enrdf_load_stackoverflow)
IL (1) IL105232A0 (enrdf_load_stackoverflow)
MX (1) MX9301837A (enrdf_load_stackoverflow)
TW (1) TW239861B (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002011766A2 (en) * 2000-08-07 2002-02-14 Laboratoire Glaxosmithkline S.A.S. Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation
WO2024067304A1 (zh) * 2022-09-28 2024-04-04 瀚远医药有限公司 一种具有Sigma2和5HT2A抑制活性的化合物及用途

Also Published As

Publication number Publication date
CN1081677A (zh) 1994-02-09
IL105232A0 (en) 1993-07-08
MX9301837A (es) 1994-02-28

Similar Documents

Publication Publication Date Title
BR9304651A (enrdf_load_stackoverflow)
DK0576346T3 (enrdf_load_stackoverflow)
DK0554977T3 (enrdf_load_stackoverflow)
DK0632741T3 (enrdf_load_stackoverflow)
BR9207065A (enrdf_load_stackoverflow)
DK0553681T3 (enrdf_load_stackoverflow)
DK0657012T3 (enrdf_load_stackoverflow)
DK0588007T3 (enrdf_load_stackoverflow)
DK0574276T3 (enrdf_load_stackoverflow)
DK0596569T3 (enrdf_load_stackoverflow)
DK0576097T3 (enrdf_load_stackoverflow)
DK0590732T3 (enrdf_load_stackoverflow)
DE9207553U1 (enrdf_load_stackoverflow)
BRPI9204323A2 (enrdf_load_stackoverflow)
BR9304980A (enrdf_load_stackoverflow)
IN177646B (enrdf_load_stackoverflow)
AU2053892A (enrdf_load_stackoverflow)
AU639880B1 (enrdf_load_stackoverflow)
AU1809592A (enrdf_load_stackoverflow)
AU1812892A (enrdf_load_stackoverflow)
AU1849392A (enrdf_load_stackoverflow)
AU1862992A (enrdf_load_stackoverflow)
AU1866292A (enrdf_load_stackoverflow)
AU1935292A (enrdf_load_stackoverflow)
AU1737992A (enrdf_load_stackoverflow)